Equasens

Equities

EQS

FR0012882389

IT Services & Consulting

Market Closed - Euronext Paris 11:35:03 2024-04-24 am EDT 5-day change 1st Jan Change
59.4 EUR -0.67% Intraday chart for Equasens +1.02% -2.78%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Equasens : RNPG virtually stable in 2023 CF
Equasens Société Anonyme Provides Revenue Guidance for the 2025 CI
Equasens Société anonyme Proposes Gross Dividend CI
Equasens: annual sales growth of almost 3% CF
Equasens Société Anonyme Reports Consolidated Revenue Results for the Fourth Quarter and Full Year of 2023 CI
Global markets live: Airbus, Tesla, HSBC, KKR, Pfizer... Our Logo
Equasens to Acquire 70% Stake in Digipharmacie MT
Equasens: acquires 70% stake in Digipharmacie CF
Equasens Société anonyme acquired 70% stake in Digipharmacie. CI
Equasens: changes to the management committee CF
Equasens Group Announces Management Appointments, Effective 1 January 2024 CI
CAC40: up slightly, stalls at the 7300 pts mark CF
Equasens: share price up, broker confirms its recommendation CF
EQUASENS : Stifel maintains its recommendation on the share CF
Equasens: acquisition of German company ADV CF
Equasens, Arz Haan Buy German Pharmacy Software Group Apotheken Datenverarbeitung MT
Equasens Société anonyme and ARZ Haan AG acquired Ad Apotheken Datenverarbeitung Gmbh & Co. Kg. CI
EQUASENS : Stifel lowers its target price CF
Stifel Cuts Equasens PT, Affirms Hold Rating MT
EQUASENS : Stifel lowers its target price CF
Equasens: sales stable in Q3 CF
Equasens Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Equasens: 11% increase in half-year net income CF
Equasens: 9% growth in half-year sales CF
Equasens Société anonyme Reports Consolidated Sales Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Chart Equasens
More charts
Equasens is No. 1 in France for publishing and integrating software programs for pharmacies, hospitals, healthcare facilities, laboratories, retirement homes and healthcare professionals. Net sales break down by activity as follows: - pharmacy software publishing and integration (73%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.; - publishing of IT solutions for health and medical/social establishments (15.2%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.); - development of solutions and infrastructures for e-Health (11.8%): digital communication, telemedicine and telehealth solutions. The group also offers financing solutions for leased goods (Nanceo). Net sales are distributed geographically as follows: France (90.9%), Italy (4.9%), Belgium and Luxembourg (2.7%), Ireland and the United Kingdom (0.8%) and Germany (0.7%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
59.4 EUR
Average target price
71.25 EUR
Spread / Average Target
+19.95%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. EQS Stock
  4. News Equasens
  5. French Healthcare Group Equasens Gets ISO Certification For PandaLab Unit